HIMSS16 – ICSA Labs Certifies Seven Health IT Vendors for Interoperability

HIMSS has entered the interoperability standards game and partnered with ICSA on the ConCert seal of approval, though this is a relatively new standard with under 20 vendors certified to date.  New vendors are receiving the ConCert approval for electronic health record interoperability.  Separately, the CommonWell Alliance also announced new members and a post acute care interoperability advancement.

Introduced at HIMSS15 in April 2015, ConCert by HIMSS offers a vendor-independent seal of approval for electronic health record (EHR), health information services provider (HISP) and health information exchange (HIE) systems. Governed by HIMSS, ConCert by HIMSS is built on the work of the EHR/HIE Interoperability Workgroup and IHE USA. ICSA Labs serves as the testing and certification body for this effort. Stella Technology designed the program’s Interoperability Test Tool.

“The development of these seven certified products is another important stride toward health information exchange across health system and state boundaries,” said George Japak, managing director, ICSA Labs. “ICSA Labs looks forward to the growth of the Concert by HIMSS program as interoperability continues to climb by increasing numbers of patients and providers.”

Seven health information technology vendors are being recognized at a HIMSS16 award ceremony for developing ConCert by HIMSS™ certified products. The ceremony will be held from 1 to 1:30 p.m. PST., March 3, at the HIMSS Interoperability Showcase Theater, booth 11954, Hall G, of the Venetian-Palazzo-Sands Expo Center.

The seven vendors are:

  • Caradigm
  • Cerner
  • Corepoint Health
  • iPatientCare
  • MEDfx
  • NextGen Healthcare
  • Qvera

To gain the ConCert by HIMSS mark for the certified products, each vendor completed a rigorous testing program to demonstrate that the product is interoperable with other products and can enable the secure, reliable, efficient and seamless transfer of data within and across organizational and state boundaries.

“In less than a year, seven vendors have responded successfully to the exciting opportunity to advance products meeting Concert by HIMSS’ rigorous standards,” said Joyce Sensmeier, vice president, informatics, HIMSS North America. “As a result, their certified products will be in the spotlight at the HIMSS Interoperability Showcase’s Testing and Certification Vignette, where HIMSS16 attendees will be able to see firsthand how certified products facilitate data exchange leading to the best point-of-care decisions and most optimal patient outcomes.”


Michael F. Arrigo

Michael is Managing Partner & CEO of No World Borders, a leading healthcare management and IT consulting firm. He serves as an expert witness in Federal and State Court and was recently ruled as an expert by a 9th Circuit Federal Judge. He serves as a patent expert witness on intellectual property disputes, both as a Technical Expert and a Damages expert. His vision for the firm is to continue acquisition of skills and technology that support the intersection of clinical data and administrative health data where the eligibility for medically necessary care is determined. He leads a team that provides litigation consulting as well as advisory regarding medical coding, medical billing, medical bill review and HIPAA Privacy and Security best practices for healthcare clients, Meaningful Use of Electronic Health Records. He advises legal teams as an expert witness in HIPAA Privacy and Security, medical coding and billing and usual and customary cost of care, the Affordable Care Act and benefits enrollment, white collar crime, False Claims Act, Anti-Kickback, Stark Law, physician compensation, Insurance bad faith, payor-provider disputes, ERISA plan-third-party administrator disputes, third-party liability, and the Medicare Secondary Payer Act (MSPA) MMSEA Section 111 reporting. He uses these skills in disputes regarding the valuation of pharmaceuticals and drug costs and in the review and audit of pain management and opioid prescribers under state Standards and the Controlled Substances Act. He consults to venture capital and private equity firms on mHealth, Cloud Computing in Healthcare, and Software as a Service. He advises ERISA self-insured employers on cost of care and regulations. Arrigo was recently retained by the U.S. Department of Justice (DOJ) regarding a significant false claims act investigation. He has provided opinions on over $1 billion in health care claims and due diligence on over $8 billion in healthcare mergers and acquisitions. Education: UC Irvine - Economics and Computer Science, University of Southern California - Business, studies at Stanford Medical School - Biomedical Informatics, studies at Harvard Medical School - Bioethics. Trained in over 10 medical specialties in medical billing and coding. Trained by U.S. Patent and Trademark Office (USPTO) and PTAB Judges on patent statutes, rules and case law (as a non-attorney to better advise clients on Technical and Damages aspects of patent construction and claims). Mr. Arrigo has been interviewed quoted in the Wall Street Journal, New York Times, and National Public Radio, Fortune, KNX 1070 Radio, Kaiser Health News, NBC Television News, The Capitol Forum and other media outlets. See https://www.noworldborders.com/news/ and https://www.noworldborders.com/clients/ for more about the company.

Leave a Reply